Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1995
11/29/1995EP0683816A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/28/1995US5470735 Insecticidal plectoxins from Plectreurys tristis
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995CA1337644C Device and process for cell capture and recovery
11/23/1995WO1995031723A1 PHAGE/PHAGEMID DISPLAY LIBRARY COMPRISING RANDOMLY CLEAVED cDNA/GENOMIC DNA OR CLONED GENE
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031531A1 Association between a novel human intracisternal a-type retroviral particle-type ii (hiap-ii) and idiopathic cd4+ t-lymphocytopenia (icl)
11/23/1995WO1995031530A1 Process for propagating avian viruses
11/23/1995WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS)
11/23/1995CA2188421A1 Alphavirus expression vector
11/22/1995EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna
11/21/1995CA1337596C Varicella-zoster virus as a live recombinant vaccine
11/16/1995WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995WO1995030761A2 Methods of in vivo gene delivery
11/16/1995WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof
11/16/1995DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines
11/16/1995CA2189582A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995CA2189452A1 Methods of in vivo gene delivery
11/15/1995EP0682108A1 Virus strain against pig pseudorabies and vaccines containing the said virus
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0462219B1 A multiple embedded nuclear polyhedrosis virus from celery looper with activity against lepidoptera
11/09/1995WO1995030018A2 Recombinant poxviruses with foreign polynucleotides in essential regions
11/09/1995WO1995029993A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
11/09/1995WO1995029991A1 A novel vzv gene, mutant vzv and immunogenic compositions
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995CA2189067A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0423240B1 Modulation of virus-host cell interactions using cyclic oligosaccharides
11/07/1995US5464621 Canine corona virus vaccine
11/02/1995WO1995029248A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO)
11/02/1995WO1995029240A1 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
11/02/1995WO1995029235A1 Spider neurotoxins and method of producing the same
11/02/1995WO1995026410A3 Biological insect control agent
11/02/1995CA2187920A1 Spider neurotoxins and method of producing the same
10/1995
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/26/1995WO1995028491A1 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
10/24/1995US5460962 Peracetic acid sterilization of collagen or collagenous tissue
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/19/1995WO1995027780A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
10/19/1995WO1995027507A1 Immunodeficiency recombinant poxvirus
10/19/1995WO1995027494A1 DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2187031A1 Immunodeficiency recombinant poxvirus
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/18/1995EP0485463B1 Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
10/17/1995US5459056 In vitro screening of viricidal drugs for AIDS
10/17/1995US5459033 Virus solution for use in immunoassays
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995WO1995006743A3 Methods and compositions for the large scale production of recombinant adeno-associated virus
10/12/1995CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/11/1995EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
10/10/1995CA1337268C Canine distemper virus vaccine
10/05/1995WO1995026411A2 Composition and methods for creating syngeneic recombinant virus-producing cells
10/05/1995WO1995026410A2 Biological insect control agent
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026405A1 T-lymphotropic primate virus l (ptlv-l) and its applications
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2185234A1 Biological insect control agent
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995EP0674497A1 Microporous macrocapsules
10/03/1995CA2054517C Recombinant adeno-associated virus vectors
09/1995
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025789A1 Highly efficient production and isolation of viral particles
09/28/1995WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
09/28/1995WO1995016048A3 Recombinant protein production in bovine adenovirus expression vector system
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673415A1 Recombinant viral vector system
09/26/1995US5453364 Recombinant poxvirus host range selection system
09/26/1995CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same
09/26/1995CA1337116C Vaccine for protection of cats against feline infectious peritonitis
09/21/1995WO1995024926A1 Formulation for use in inducing cytotoxic t-cells
09/21/1995WO1995024925A1 Cytotoxic t-cell epitopes
09/21/1995CA2185540A1 Formulation for use in inducing cytotoxic t-cells
09/20/1995EP0672192A1 Method for inhibition of viral morphogenesis
09/20/1995EP0672158A1 Virus with modified binding moiety specific for the target cells
09/20/1995EP0672157A1 Recombinant viruses comprising artificial proteolytic cleavage site
09/20/1995EP0672153A1 Vector to deliver and express foreign gene
09/20/1995EP0672121A1 Papillomavirus: biosynthetic process and assays
09/20/1995EP0672066A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
09/20/1995EP0671926A1 Immunomodulatory peptides
09/19/1995US5451499 Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
09/14/1995WO1995024470A1 Activating virus
09/14/1995WO1995024468A1 Hepatitis a virus culture process
09/14/1995WO1995024467A1 Serum-free production of packaged viral vector
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 267